Pathophysiology of cardiovascular disease in hemodialysis patients. Cardiovascular
disease is the principal cause of morbidity and mortality in dialysis patients. The principal …

Although accelerated atherosclerosis and arteriosclerosis are common in patients with renal
failure, the pathogenesis of these changes is poorly understood. Parathyroid hormone (PTH) …

Background. Epidemiological studies have identified aortic stiffness as an independent
predictor of cardiovascular mortality in end‐stage renal disease (ESRD) patients. In these …

Current literature suggests associations between abnormal mineral metabolism (MM) to
cardiovascular disease in dialysis populations, with conflicting results. MM physiology is …

Epidemiological studies have shown that damage of large conduit arteries is a major
contributing factor to morbidity and mortality in patients with chronic kidney disease and in …

Background Hyperparathyroidism is reported in 10% to 66% of renal transplant recipients
(RTR). The influence of persisting hyperparathyroidism on long-term clinical outcomes in …

In children, cardiac abnormalities such as increased left ventricular mass (LVM) and
diastolic dysfunction develop at the time of mild to moderate chronic renal insufficiency (CRI) …

Background. Successful kidney transplantation is believed to reverse secondary
hyperparathyroidism, but persistent disease has emerged in a significant number of allograft …

Objective: To provide a review on current knowledge about the pathogenesis, epidemiology,
and clinical complications of persistent hyperparathyroidism after kidney transplantation …

Secondary and tertiary hyperparathyroidism (HPT) develop in patients with renal failure due
to a variety of mechanisms including increased phosphorus and fibroblast growth factor 23 …